Eternity Healthcare to Develop a Noninvasive Saliva-Based Sugar Monitor Device

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Eternity Healthcare Inc. ETAH 0.00% , a leading medical device and diagnostic company with special focus on diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood.

There are an estimated 28 million diabetics in the United States and this number is growing. The worldwide number of diabetics is estimated to be over 200 million. Diabetic patients are divided into type 1 and type 2. Type 1 diabetics require painful finger pricking and insulin injections 3-5 times a day and about 50% of the type 2 diabetics also require painful finger pricking and insulin injections.

Dr. Salari, C.E.O. states that "Eternity Healthcare will be the first company to focus on the development of an alternative saliva based glucose monitoring test. This new test should reduce the patient's reliance on painful finger pricking and blood collection."

http://www.marketwatch.com/story/et...-for-diabetes-2014-02-04?reflink=MW_news_stmp
 
Status
Not open for further replies.
Back
Top